UBS Group AG - CHINA SXT PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

CHINA SXT PHARMACEUTICALS IN's ticker is and the CUSIP is G2161P132. A total of 6 filers reported holding CHINA SXT PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
UBS Group AG ownership history of CHINA SXT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$3,674
-27.9%
29,870
+66.5%
0.00%–
Q1 2023$5,096
-11.1%
17,945
+69.0%
0.00%–
Q4 2022$5,733
-4.4%
10,616
+37.4%
0.00%–
Q3 2022$6,000–7,725–0.00%–
 Download
Other shareholders
CHINA SXT PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
Renaissance Technologies 21,572$17,0000.00%
Hudock, Inc. 300$00.00%
UBS Group AG 7,725$6,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 45,685$35,0000.00%
HRT FINANCIAL LP 10,870$8,0000.00%
View complete list of CHINA SXT PHARMACEUTICALS IN shareholders